Business · 07/10/2020

FDA Announces Fee Rate for Material Threat Medical Countermeasure Priority Review Voucher for Fiscal Year 2021

The US Food and Drug Administration (FDA) has set the fee rate for using a material threat medical countermeasure (MCM) priority review voucher for fiscal year 2021, based on the average costs incurred by the agency in reviewing priority and non-priority applications in the previous year.